You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced urothelial carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)

Not yet recruiting
  • Advanced Solid Tumors Cancer
  • +3 more
  • New York, New York
    Memorial Slone Kettering Cancer Center
Jun 26, 2023

Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 27, 2023

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)

Not yet recruiting
  • Locally Advanced Urothelial Carcinoma
  • +3 more
  • (no location specified)
Sep 15, 2022

Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Bern, Switzerland
    University Hospital Insel
Feb 20, 2023

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

Recruiting
  • Advanced Urothelial Carcinoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jun 28, 2022

Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Bladder Cancer
  • Tampa, Florida
  • +2 more
Jun 9, 2022

Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

Active, not recruiting
  • Urinary Bladder Cancer
  • München, Germany
  • +2 more
Oct 19, 2022

Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

Recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 8, 2023

Urothelial Carcinoma Trial in France (Talazoparib + Avelumab)

Recruiting
  • Urothelial Carcinoma
  • Talazoparib + Avelumab
  • Angers, France
  • +13 more
Aug 9, 2022

Advanced Urothelial Carcinoma Trial in Beijing (anti-PD-L1 antibody, albumin bound paclitaxel)

Active, not recruiting
  • Advanced Urothelial Carcinoma
  • anti-PD-L1 antibody
  • albumin bound paclitaxel
  • Beijing, Beijing, China
    Beijing Tumor Hospital
Jan 20, 2022

Metastatic Urothelial Carcinoma, Urothelial Tumors Trial (Coformulated favezelimab/pembrolizumab, Coformulated

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Urothelial Neoplasms
  • Coformulated favezelimab/pembrolizumab
  • +3 more
  • (no location specified)
Apr 26, 2023

Avelumab First-Line Maintenance in Canadian People With Advanced

Not yet recruiting
  • Urinary Bladder Neoplasms
  • +3 more
  • Avelumab first-line maintenance
  • Mississauga, Ontario, Canada
    Bayshore Specialty Rx
Jan 24, 2023

Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
  • +3 more
  • Cabozantinib S-malate
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 8, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +13 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 8, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 27, 2023

Muscle Invasive Bladder Cancer, Urothelial Carcinoma, Neoadjuvant Chemo Trial in Yangsan (dose dense MVAC with pegylated GCSF)

Recruiting
  • Muscle Invasive Bladder Cancer
  • +2 more
  • dose dense MVAC with pegylated GCSF
  • Yangsan, Gyeongsangnam-do, Korea, Republic of
    Pusan National University Yangsan Hospital
Feb 2, 2022

Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023

Urothelial Carcinoma Trial (Avelumab)

Not yet recruiting
  • Urothelial Carcinoma
  • (no location specified)
Oct 26, 2022

Melanoma, Urothelial Carcinoma Trial in China (QLF31907)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Beijing, Beijing, China
  • +5 more
Apr 9, 2023

Urothelial Carcinoma Trial in United States (Carboplatin, Gemcitabine, Atezolizumab)

Active, not recruiting
  • Urothelial Carcinoma
  • Indianapolis, Indiana
  • +3 more
Feb 14, 2022

Urothelial Carcinoma, Bladder Cancer, Transitional Cell Carcinoma Trial in United States (nab-paclitaxel, Gemcitabine)

Terminated
Has Results
  • Urothelial Carcinoma
  • +2 more
  • Fort Myers, Florida
  • +4 more
Dec 15, 2021

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Los Angeles, California
  • +2 more
Jun 28, 2022

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023